SJS Investment Consulting’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.55K Buy
45
+32
+246% +$3.31K ﹤0.01% 1428
2026
Q1
$1.26K Buy
13
+1
+8% +$103 ﹤0.01% 1396
2025
Q4
$1.27K Hold
12
﹤0.01% 1231
2025
Q3
$1.52K Hold
12
﹤0.01% 892
2025
Q2
$1.47K Sell
12
-7
-37% -$799 ﹤0.01% 674
2025
Q1
$1.93K Buy
19
+1
+6% +$98 ﹤0.01% 742
2024
Q4
$1.66K Sell
18
-4
-18% -$393 ﹤0.01% 797
2024
Q3
$2.13K Hold
22
﹤0.01% 759
2024
Q2
$1.89K Hold
22
﹤0.01% 744
2024
Q1
$1.82K Hold
22
﹤0.01% 795
2023
Q4
$1.47K Sell
22
-2
-8% -$130 ﹤0.01% 792
2023
Q3
$1.61K Buy
24
+2
+9% +$138 ﹤0.01% 729
2023
Q2
$1.49K Buy
22
+4
+22% +$251 ﹤0.01% 727
2023
Q1
$974 Sell
18
-6
-25% -$349 ﹤0.01% 908
2022
Q4
$1.44K Buy
24
+7
+41% +$381 ﹤0.01% 780
2022
Q3
$0 Buy
+17
New +$850 ﹤0.01% 1173
2022
Q1
$0 Buy
+4
New +$209 ﹤0.01% 866

Other funds holding EHC

SJS Investment Consulting's EHC Position: Q2 2026 in Review

SJS Investment Consulting increased its Encompass Health (EHC) stake by 246% in Q2 2026, buying an estimated $3.31K and bringing the position to 45 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1428.

SJS Investment Consulting first reported a position in EHC in Q1 2022 and has held it in 17 quarters since. 276 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • SJS Investment Consulting held 45 shares of Encompass Health worth $4.55K as of Q2 2026.
  • SJS Investment Consulting bought 32 Encompass Health shares in Q2 2026, an estimated $3.31K.
  • Encompass Health made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1428 holding.
  • SJS Investment Consulting first reported a position in Encompass Health in Q1 2022 and has held it in 17 quarters since.
  • 276 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.